Myriad Genetics (MYGN) PT Raised to $28 at Raymond James
Tweet Send to a Friend
Raymond James analyst Andrew Cooper raised the price target on Myriad Genetics (NASDAQ: MYGN) to $28.00 (from $25.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
